1997
DOI: 10.1007/s004390050599
|View full text |Cite
|
Sign up to set email alerts
|

An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants

Abstract: Immortalized B lymphocytes from Werner syndrome subjects are shown to be hypersensitive to 4-nitroquinoline-1-oxide (4NQO), supporting earlier work on T lymphocytes. We also show that B cell lines from clinically normal heterozygous carriers exhibit sensitivities to this genotoxic agent, which are intermediate to those of wild-type and homozygous mutants. 4NQO is shown to induce an apoptotic response. These data encourage research on DNA repair with such cell lines and raise the question of an enhanced sensiti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
139
0
3

Year Published

1999
1999
2012
2012

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 177 publications
(147 citation statements)
references
References 18 publications
5
139
0
3
Order By: Relevance
“…1A). The rationale for these experiments was provided by previous work showing intermediate sensitivity of WRN heterozygous lymphoblastoid cell lines to several DNA damaging agents including cis-Pt [24,25] and the identification of genetic instability in vivo in the red blood cell lineage of WRN heterozygotes [26].…”
Section: Resultsmentioning
confidence: 99%
“…1A). The rationale for these experiments was provided by previous work showing intermediate sensitivity of WRN heterozygous lymphoblastoid cell lines to several DNA damaging agents including cis-Pt [24,25] and the identification of genetic instability in vivo in the red blood cell lineage of WRN heterozygotes [26].…”
Section: Resultsmentioning
confidence: 99%
“…Noteworthy, yeast mutants in such RecQ-like helicases are extremely sensitive to agents that cause replication arrest, such as hydroxyurea because of uncontrolled illegitimate recombinational events (Stewart et al, 1997;Yamagata et al, 1998). The observed sensitivity of WS cells to 4-nitroquinoline-1-oxide (Gebhart et al, 1988;Ogburn et al (Lebel and Leder, 1998;Poot et al, 1999;Pichierri et al, 2000). For these reasons, it has been proposed that the primary defect of this disorder is "unprotected synthesis," that is, the failure of cells to protect the integrity of the genoma during the DNA replication process (Chakraverty and Hickson, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…Noteworthy, yeast mutants in such RecQ-like helicases are extremely sensitive to agents that cause replication arrest, such as hydroxyurea because of uncontrolled illegitimate recombinational events (Stewart et al, 1997;Yamagata et al, 1998). The observed sensitivity of WS cells to 4-nitroquinoline-1-oxide (Gebhart et al, 1988;Ogburn et al, 1997) has prompted a search for sensitivity toward drugs that interfere with DNA replication and transcription. More recently, the finding that WS cells show sensitivity to camptothecin, an agent that produces replication-dependent DNA damage, reinforces the hypothesis that WRN functions mainly during the DNA replication processes (Lebel and Leder, 1998;Poot et al, 1999;Pichierri et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Clinicians should be aware of the possibility of elevated drug sensitivities to genotoxic agents in this patient population. 17 …”
Section: Infarction Management (Please Describe)mentioning
confidence: 99%
“…Clinicians should be aware of the potential for increased sensitivity to genotoxic drugs. 17 An affected person could learn that his or her children are unlikely to be affected by Werner syndrome.…”
Section: If Applicable Further Consequences Of Testingmentioning
confidence: 99%